177Lu-EDTMP for palliation of pain from bone metastases in patients with prostate and breast cancer: a phase II study

Efficacy and Safety of 177Lu-EDTMP in Bone Metastatic Pain Palliation in Breast Cancer and Hormone Refractory Prostate Cancer

(2013) Jie Yuan et al.   CLINICAL NUCLEAR MEDICINE

Radionuclide Therapy of Bone Metastases

(2012) Manfred Fischer et al.   Breast Care

Two-Year Survival Follow-Up of the Randomized, Double-Blind, Placebo-Controlled Phase II Study of Radium-223 Chloride in Patients With Castration-Resistant Prostate Cancer and Bone Metastases

(2012) Sten Nilsson et al.   Clinical Genitourinary Cancer

A Randomized, Double-Blind, Dose-Finding, Multicenter, Phase 2 Study of Radium Chloride (Ra 223) in Patients with Bone Metastases and Castration-Resistant Prostate Cancer

(2012) Christopher C. Parker et al.   EUROPEAN UROLOGY

Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation

(2010) Imtiaz Ahmed Abbasi   NUCLEAR MEDICINE AND BIOLOGY

Multispecies animal investigation on biodistribution, pharmacokinetics and toxicity of 177Lu-EDTMP, a potential bone pain palliation agent

(2009) Domokos Máthé et al.   NUCLEAR MEDICINE AND BIOLOGY

177Lu-EDTMP: A Viable Bone Pain Palliative in Skeletal Metastasis

(2007) Sudipta Chakraborty et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS